ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $58,692,000 | +1308.8% | 3,112,051 | +779.2% | 0.09% | +1450.0% |
Q2 2019 | $4,166,000 | -13.9% | 353,952 | -0.1% | 0.01% | -14.3% |
Q1 2019 | $4,839,000 | -1.1% | 354,469 | -25.7% | 0.01% | -12.5% |
Q4 2018 | $4,892,000 | +65.3% | 477,310 | +168.5% | 0.01% | +100.0% |
Q3 2018 | $2,960,000 | -36.7% | 177,772 | -39.9% | 0.00% | -33.3% |
Q2 2018 | $4,673,000 | +110.8% | 295,730 | +69.4% | 0.01% | +100.0% |
Q1 2018 | $2,217,000 | -5.3% | 174,555 | -14.6% | 0.00% | 0.0% |
Q4 2017 | $2,341,000 | -26.7% | 204,423 | -26.7% | 0.00% | -50.0% |
Q2 2017 | $3,192,000 | +1.4% | 278,728 | +84.1% | 0.01% | 0.0% |
Q1 2017 | $3,149,000 | +475.7% | 151,371 | +475.3% | 0.01% | +500.0% |
Q4 2016 | $547,000 | +11.2% | 26,312 | +75.4% | 0.00% | 0.0% |
Q3 2016 | $492,000 | +31.2% | 15,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $375,000 | -98.6% | 15,000 | -98.1% | 0.00% | -98.2% |
Q4 2015 | $26,058,000 | -47.2% | 788,913 | -47.6% | 0.06% | -42.1% |
Q3 2015 | $49,307,000 | -36.8% | 1,505,099 | +2.2% | 0.10% | -35.8% |
Q2 2015 | $77,994,000 | +454.6% | 1,472,425 | +202.2% | 0.15% | +469.2% |
Q1 2015 | $14,063,000 | +3032.1% | 487,290 | +3059.7% | 0.03% | +2500.0% |
Q4 2014 | $449,000 | -57.8% | 15,422 | -81.6% | 0.00% | -66.7% |
Q3 2014 | $1,065,000 | – | 83,973 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |